Watch the Demo
Learn how to use the Strep A 2 test by watching this product demonstration.
global Point Of Care
ID NOW™
MOLECULAR. IN MINUTES.
Rapid, Molecular Results at the Point of Care
The ID NOW™ Platform is a rapid, instrument-based, isothermal system for the qualitative detection of infectious diseases. Our unique ID NOW™ isothermal nucleic acid amplification technology (NAAT) provides molecular results in just minutes, allowing you to make effective clinical decisions sooner.
MOLECULAR. IN MINUTES.
Rapid, Molecular Results at the Point of Care
The ID NOW™ Platform is a rapid, instrument-based, isothermal system for the qualitative detection of infectious diseases. Our unique ID NOW™ isothermal nucleic acid amplification technology (NAAT) provides molecular results in just minutes, allowing you to make effective clinical decisions sooner.
Benefits
The intuitively designed ID NOW™ instrument can have a positive impact in any healthcare setting.
- Easy to use with only minimal training requirements
- Large visual touchscreen displays results, eliminating transcription errors and the need for printing
- Small footprint saves you bench space and can be used in any healthcare setting
- QC lock-out
- Bi-directional connectivity
- Eliminates interpretation and transcription errors
- Gives you the confidence to make clinical decisions sooner
- Facilitates effective patient management
- Enables prompt initiation of infection control measures
- Aids targeted antiviral therapy and Antimicrobial Stewardship
- Reliable near-patient testing reduces overall healthcare costs1
SIMPLE AND SECURE RESULTS REPORTING
Track, consolidate and report ID NOW™ test results from multiple decentralized instruments and locations using AegisPOC™.
Illuminating Insights: Rapid Molecular Testing for Respiratory Disease
Rapid molecular testing is an important tool in the fight against respiratory infectious disease. The ID NOW™ platform can lead to faster diagnosis and better overall patient care.
ID NOW™ is significantly faster than other molecular methods and more accurate than conventional rapid tests.
Helpful Documents
PRODUCT DOCUMENTS
PRODUCT CODE
| ID NOW™ System | Code |
|---|---|
| ID NOW™ Instrument | NAT-000 (Global) |
| ID NOW™ COVID-19 2.0 Test Kit | 192-000 (Australia) |
| ID NOW™ COVID-19 2.0 Test Kit | 193-000 |
| ID NOW™ COVID-19 2.0 Control Kit (12 positive, 12 blank swabs) | 192-080 |
| ID NOW™ Influenza A & B 2 24 Test Kit | 427-000 (Global) |
| ID NOW™ Influenza A & B Control Swab Kit | 425-080 (Global) |
| ID NOW™ Strep A 2 24 Test Kit | 734-000 (Global) |
| ID NOW™ Strep A 2 Control Swab Kit | 734-080 (Global) |
| ID NOW™ RSV 24 Test Kit | 435-000 (Global) |
| ID NOW™ RSV Control Swab Kit | 435-080 (Global) |
| COVID-19 Swab Transport Tube Accessory Pack 24 Count | 190-010 |
| ID NOW™ Barcode Scanner | OPR2001ZWU1-201 (Global) |
| Universal Printer | 55115 (Global) |
| IDNOWPRINT |
Videos
Watch the Technology Video
Learn how Abbott utilizes unique isothermal nucleic acid amplification technology.
View References
- Bonner, A.B. et al. (2003) Impact of the Rapid Diagnosis of Influenza on Physician Decision-Making and Patient Management in the Pediatric Emergency Department: Results of a Randomized, Prospective, Controlled Trial. Pediatrics Vol. 112 No. 2.
